Detecting breast cancer with non-contrast MR imaging: combining diffusion-weighted and STIR imaging.

We combined diffusion-weighted (DWI) and short TI inversion recovery (STIR) imaging to evaluate the diagnostic capability of non-contrast magnetic resonance (MR) imaging to detect breast cancer. Seventy women patients underwent mammography and MR imaging with combined DWI (b factor: 1000) and STIR that revealed malignancy, and postoperative pathological examination confirmed breast cancer. Interpreted images were evaluated for sensitivity, false negative rate (FN), sensitivity by pT, and sensitivity by background density of the mammary gland. Of the 70 cases, 68 were diagnosed as cancer by DWI and STIR (sensitivity, 97% [68/70]; FN, 2.9% [2/70]). Sensitivities by pT were: pTis, 67% (4/6); pT1, 100% (33/33); and pT2-4, 100% (31/31). No significant differences were observed in sensitivity between pT1 and pT2-4 (P<0.001). Sensitivities by background density of mammary gland were: fatty/scattered fibroglandular tissue, 95% (20/21) and heterogeneous fibroglandular tissue/mostly fibroglandular tissue, 98% (48/49). No significant differences were observed (P<0.001). Two cases, an intraductal and an apocrine carcinoma, were incorrectly diagnosed by MR imaging. Precise diagnosis of breast cancer is possible with combined DWI and STIR, even in non-contrast MR imaging, regardless of the diameter or background density of mammary gland. It is hoped that non-contrast MR imaging that combines DWI and STIR will become an established clinical screening method.

[1]  Masahiko Watanabe,et al.  Diffusion-Weighted Imaging of Malignant Breast Tumors: The Usefulness of Apparent Diffusion Coefficient (ADC) Value and ADC Map for the Detection of Malignant Breast Tumors and Evaluation of Cancer Extension , 2005, Journal of computer assisted tomography.

[2]  B. Baumert,et al.  High precision focused irradiation in the form of fractionated stereotactic conformal radiotherapy (SCRT) for benign meningiomas predominantly in the skull base location. , 2002, Clinical oncology (Royal College of Radiologists (Great Britain)).

[3]  Shigeru Nawano,et al.  Efficacy of MR mammography (MRM) in providing preoperative locoregional information on breast cancer: correlation between MRM and histological findings. , 2002, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[4]  A. Hanlon,et al.  Second cancers after conservative surgery and radiation for stages I-II breast cancer: identifying a subset of women at increased risk. , 2001, International journal of radiation oncology, biology, physics.

[5]  T. M. Kolb,et al.  Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. , 2002, Radiology.

[6]  I. Ellis,et al.  Prognostic significance of synchronous and metachronous bilateral breast cancer , 2001, World Journal of Surgery.

[7]  O. Olopade,et al.  Efficacy of Risk‐Reducing Salpingo‐Oophorectomy in Women with BRCA‐1 and BRCA‐2 Mutations , 2004, The breast journal.

[8]  E A Sickles,et al.  Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability. , 2000, AJR. American journal of roentgenology.

[9]  C. Lehman,et al.  Report of the Working Groups on Breast MRI: Report of the High‐Risk Screening Group , 2004, The Breast Journal.

[10]  J Benichou,et al.  Graphs to estimate an individualized risk of breast cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  N. Hylton,et al.  Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: Results from the International Breast Magnetic Resonance Consortium (IBMC) trial , 2005, Journal of surgical oncology.

[12]  Takayuki,et al.  DiŠusion-weighted Imaging of Breast Cancer with the Sensitivity Encoding Technique: Analysis of the Apparent DiŠusion Coe‹cient Value , 2004 .

[13]  D. Vanel.  The American College of Radiology (ACR) Breast Imaging and Reporting Data System (BI-RADS): a step towards a universal radiological language? , 2007, European journal of radiology.

[14]  S. Warach,et al.  Pitfalls and potential of clinical diffusion-weighted MR imaging in acute stroke. , 1997, Stroke.

[15]  N Risch,et al.  Autosomal dominant inheritance of early‐onset breast cancer. Implications for risk prediction , 1994, Cancer.

[16]  Kathleen R Gundry,et al.  The application of breast MRI in staging and screening for breast cancer. , 2005, Oncology.

[17]  S. Nawano,et al.  Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. , 2006, Radiology.

[18]  J Chang-Claude,et al.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.

[19]  Shigeru Nawano,et al.  Diffusion-weighted imaging of breast cancer with the sensitivity encoding technique: analysis of the apparent diffusion coefficient value. , 2004, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[20]  N. Weiss,et al.  Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer. , 2001, Journal of the National Cancer Institute.

[21]  S. G. Orel.  1–10 Efficacy of MRI and Mammography for Breast-Cancer Screening in Women With a Familial or Genetic Predisposition , 2005 .

[22]  M. Noguchi,et al.  Breast cancer in dense breast: Detection with contrast‐enhanced dynamic MR imaging , 2000, Journal of magnetic resonance imaging : JMRI.

[23]  D. Dershaw,et al.  Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.